Changchun Genescience Pharmaceutical Co., Ltd.

This phase 2 study tested whether GS1-144 tablets can reduce moderate to severe hot flashes in Chinese women going through menopause. 129 women took either the drug or a placebo for 12 weeks. The main goal was to see if the drug lowered the number and severity of hot flashes and …

This early-stage study tested a single injection of a new drug, GenSci120, in 58 healthy adults in China. The main goal was to check if the drug is safe and how the body processes it. This study does not aim to treat any disease, but the information gathered will help design futu…